Imaging: Prostate Cancer VL

CONDOR: Study of 18F-DCFPyL PET/CT Imaging in Patients with Suspected Recurrence of Prostate Cancer - Michael J. Morris

Details
Michael Morris Oliver Sartor and Alicia Morgans discuss the CONDOR study, the second of two prospective clinical trials designed in collaboration with the FDA to demonstrate the diagnostic performance of PyL in patients with biochemically recurrent prostate cancer. Correct localization rate (CLR), or the positive predictive value of the PyL scan, was established as the primary endpoint and the CLR...

68Ga-PSMA PET: A Novel Imaging Technique Prior to Radical Prostatectomy in Men with Intermediate or High Risk Prostate Cancer - Thomas Hope

Details
In conversation with Charles Ryan, Thomas Hope details the prospective, multicenter single-arm open-label phase 3 imaging trial evaluating the accuracy of 68Ga-PSMA-11 for pelvic nodal metastasis detection prior to radical prostatectomy or definitive treatment and pelvic lymph node dissection. Between UCLA and UCSF 277 patients went through prospective imaging. When comparing these patients to nod...

PSMA PET/CT Imaging for Staging High-risk Prostate Cancer Prior to Curative-intent Surgery or Radiotherapy (proPSMA) - Michael Hofman and Declan Murphy

Details
Declan Murphy and Michael Hofman join Alicia Morgans to discuss the results from proPSMA study "A prospective randomized multi-center study of the impact of Ga-68 PSMA-PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy." Conventional imaging using CT and bone scan has insufficient sensitivity when staging men with high-risk localized prostate canc...

Ga-68 PSMA PET/CT Promising New Technique for Predicting Risk Stratification and Metastatic Risk of Prostate Cancer Patients - Chen Liu

Details
In this presentation, Chen Liu focuses on Gallium-68 PSMA 617 PET/CT for predicting risk and metastases in prostate cancer patients. In this study being discussed, Dr. Liu and colleagues explored the possibility to establish a noninvasive prostate cancer risk stratification criteria based on imaging analysis. They aimed to investigate the performance of gallium-68-PSMA PET/CT in predicting the ris...

The Use of Novel Imaging Methods in Prostate Cancer - Stefano Fanti

Details
Stefano Fanti joins Phillip Koo at the 2019 European Associate of Urology to discuss the use of novel imaging methods in the prostate cancer space. Their discussion highlights the excitement and limitations around imaging including the methods of MRI and PET, and its impacts on patient care. Biographies: Stefano Fanti, Professor Department of Experimental, Diagnostic and Specialty Medicine - DIMES...

Insights on Nuclear Imaging for Prostate Cancer- Stefano Fanti

Details
Stefano Fanti reviews the consensus paper on nuclear imaging for prostate cancer which was recently published in Lancet Oncology in December 2018. PSMA PET should be offered early in biochemical recurrence as it is the most sensitive and the EAU has incorporated PSMA PET into their guidelines as well, recommending PSMA PET for PSA >0.2. Stefano and Alicia discuss the various PSMA technologies and...

Incorporate Next Generation Imaging Tools Into Clinical Practice - Piet Ost

Details
Piet Ost shares details of his recent presentation focusing on biochemical recurrent prostate cancer, specifically in the recurrent setting, and answering the question such as should we be investing in this novel imaging for all patients or should we dial back a bit and only have that for selected patients? Who should get this imaging?. He expressed his intent to try to convince people to think be...

Definitions and Concepts of Oligometastatic Prostate Cancer - Interview with Robert Reiter

Details
Robert Reiter and Phillip Koo discuss his lecture on oligometastatic disease at the Advanced Prostate Cancer Consensus Conference (APCCC 2019). Dr. Reiter highlights next-generation imaging and its impact on managing patients with oligometastatic disease. Biographies: Robert E. Reiter, MD, MBA, the Bing Professor of Urologic Oncology and Director of UCLA's prostate cancer program, Director of Urol...

The Future of Advanced Prostate Cancer Imaging Presentation - Stefano Fanti

Details
Stefano Fanti presents his point of view on the future of prostate cancer imaging at the Advanced Prostate Cancer Consensus Conference (APCCC 2019). He shares his thoughts on the use of conventional imaging such as CT and bone scan and why they should be regarded as obsolete, and why novel imaging such as PET PSMA and MRI should be incorporated into practice immediately. Dr. Fanti believes that th...

Integrating Advanced Molecular Imaging into Clinical Practice - Michael Morris

Details
Michael Morris joins Alicia Morgans to discuss advanced molecular imaging, and how we can take the data we have and integrate it into our clinical practices. They discuss recent results of the Prostate Cancer Working Group as well as the patient where advanced molecular imaging is most useful. Finally, Dr. Morris provides his recommendation to clinicians gaining access to these scans and how to us...